2-Bromo-6-fluorobenzoic acid | CAS:2252-37-1

We serve 2-Bromo-6-fluorobenzoic acid CAS:2252-37-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-6-fluorobenzoic acid

Chemical Name:2-Bromo-6-fluorobenzoic acid
CAS.NO:2252-37-1
Synonyms:6-Bromo-2-fluorobenzoic acid; 
2-bromo-6-fluoro-benzoic acid;
Molecular Formula:C7H4BrFO2
Molecular Weight:219.00800
 
Physical and Chemical Properties:
Density:1.789;
Melting point:153-155oC;
Boiling point:286.1oC;
Flash point:126.8oC;
Index of Refraction:1.567;
 
Specification:
Appearance:Off-white powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2-Bromo-6-fluorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-6-fluoro-benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Bromo-2-fluorobenzoic acid Use and application,6-Bromo-2-fluorobenzoic acid technical grade,usp/ep/jp grade.


Related News: Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.3,5-Dimethylpyrazole manufacturer Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.benzyl 2,3,3a,4,5,6,7,7a-octahydro-1H-indole-2-carboxylate,hydrochloride supplier The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.Although bird flu poses more of a danger to poultry than humans — it is not easily transmissible among people — the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic.